Company intelligence / Profile preview
Qionglai Tianyin Pharmaceutical Co., Ltd.
Qionglai, Sichuan Sheng, Chinabiospace.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Qionglai Tianyin Pharmaceutical operates as a manufacturing base for modernized traditional Chinese medicines, with at least one herbal medicine product approved in China targeting ischemic stroke. The facility supports both pre-extraction and formulation processes for TCM products. It is part of the broader pipeline and commercial operations of its parent, Tianyin Pharmaceutical Co., Inc.
- Therapeutic areas
- Cardiovascular
- Modalities
- Herbal medicine
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Buchang Pharmaceuticals
Beyond the preview
Go deeper on Qionglai Tianyin Pharmaceutical Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Qionglai Tianyin Pharmaceutical Co., Ltd..